Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies

Abstract Autoantibodies are the diagnostic hallmark of autoimmune liver diseases. Indirect immunofluorescence (IFT) is the reference method for the detection of anti-mitochondrial antibodies (AMA) and anti-liver kidney microsomal type-1 (anti-LKM1) antibodies, and inhibition ELISA (iELISA) for anti-...

Full description

Bibliographic Details
Main Authors: Alejandro Campos-Murguia, Nicole Henjes, Stephanie Loges, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-37095-z
_version_ 1827917056288227328
author Alejandro Campos-Murguia
Nicole Henjes
Stephanie Loges
Heiner Wedemeyer
Elmar Jaeckel
Richard Taubert
Bastian Engel
author_facet Alejandro Campos-Murguia
Nicole Henjes
Stephanie Loges
Heiner Wedemeyer
Elmar Jaeckel
Richard Taubert
Bastian Engel
author_sort Alejandro Campos-Murguia
collection DOAJ
description Abstract Autoantibodies are the diagnostic hallmark of autoimmune liver diseases. Indirect immunofluorescence (IFT) is the reference method for the detection of anti-mitochondrial antibodies (AMA) and anti-liver kidney microsomal type-1 (anti-LKM1) antibodies, and inhibition ELISA (iELISA) for anti-soluble liver antigen (anti-SLA) antibodies. Given the complexity of these techniques, commercial ELISAs have emerged as a practical alternative, but without head-to-head validations. This study evaluated the agreement between three commercial ELISAs and the reference techniques and the impact of polyreactive immunoglobulin G (pIgG), a recently described phenomenon in autoimmune hepatitis, on commercial ELISAs. Inter-rater reliability was assessed using Cohen-Kappa coefficient (κ). Forty-eight, 46, and 66 samples were analyzed for AMA, anti-LKM1, and anti-SLA, respectively. For AMA, one commercial assay showed high agreement (κ = 0.91 (0.78–1.00)) with the reference method, while the other two showed weak or moderate agreement. For anti-LKM1, only one commercial assay showed high agreement (κ = 0.86 (0.71–1.0)). For anti-SLA antibodies only moderate agreement was achieved (κ up to 0.71 (0.52–0.89)). There was a trend towards higher pIgG levels in false-positives in the commercial ELISAs. Patients with high suspicion of autoimmune liver diseases should be referred to reference laboratories with the capacity of performing gold standard methods if the initial ELISA-based screening was performed.
first_indexed 2024-03-13T03:23:18Z
format Article
id doaj.art-8d9ac42811f34a7b95b746a234a1db07
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T03:23:18Z
publishDate 2023-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8d9ac42811f34a7b95b746a234a1db072023-06-25T11:13:23ZengNature PortfolioScientific Reports2045-23222023-06-0113111110.1038/s41598-023-37095-zEvaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodiesAlejandro Campos-Murguia0Nicole Henjes1Stephanie Loges2Heiner Wedemeyer3Elmar Jaeckel4Richard Taubert5Bastian Engel6Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical SchoolAbstract Autoantibodies are the diagnostic hallmark of autoimmune liver diseases. Indirect immunofluorescence (IFT) is the reference method for the detection of anti-mitochondrial antibodies (AMA) and anti-liver kidney microsomal type-1 (anti-LKM1) antibodies, and inhibition ELISA (iELISA) for anti-soluble liver antigen (anti-SLA) antibodies. Given the complexity of these techniques, commercial ELISAs have emerged as a practical alternative, but without head-to-head validations. This study evaluated the agreement between three commercial ELISAs and the reference techniques and the impact of polyreactive immunoglobulin G (pIgG), a recently described phenomenon in autoimmune hepatitis, on commercial ELISAs. Inter-rater reliability was assessed using Cohen-Kappa coefficient (κ). Forty-eight, 46, and 66 samples were analyzed for AMA, anti-LKM1, and anti-SLA, respectively. For AMA, one commercial assay showed high agreement (κ = 0.91 (0.78–1.00)) with the reference method, while the other two showed weak or moderate agreement. For anti-LKM1, only one commercial assay showed high agreement (κ = 0.86 (0.71–1.0)). For anti-SLA antibodies only moderate agreement was achieved (κ up to 0.71 (0.52–0.89)). There was a trend towards higher pIgG levels in false-positives in the commercial ELISAs. Patients with high suspicion of autoimmune liver diseases should be referred to reference laboratories with the capacity of performing gold standard methods if the initial ELISA-based screening was performed.https://doi.org/10.1038/s41598-023-37095-z
spellingShingle Alejandro Campos-Murguia
Nicole Henjes
Stephanie Loges
Heiner Wedemeyer
Elmar Jaeckel
Richard Taubert
Bastian Engel
Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
Scientific Reports
title Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
title_full Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
title_fullStr Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
title_full_unstemmed Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
title_short Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
title_sort evaluation of immunoserological detection of anti liver kidney microsomal anti soluble liver antigen and anti mitochondrial antibodies
url https://doi.org/10.1038/s41598-023-37095-z
work_keys_str_mv AT alejandrocamposmurguia evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT nicolehenjes evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT stephanieloges evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT heinerwedemeyer evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT elmarjaeckel evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT richardtaubert evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies
AT bastianengel evaluationofimmunoserologicaldetectionofantiliverkidneymicrosomalantisolubleliverantigenandantimitochondrialantibodies